CVS adds four new board members in deal with Glenview as CEO pursues a turnaround By Reuters
By Sriparna Roy (Reuters) -CVS Health added Glenview Capital’s top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate tasked a new CEO with its turnaround efforts. The company has been facing pressure from investors including Glenview to improve its operations and shareholder value after missing financial targets several times due to increased medical costs in its health insurance